BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
Vanda Pharmaceuticals, Inc. (NQ: VNDA)
8.510 USD  UNCHANGED
Official Closing Price  /  Updated: 4:00 PM EDT, Jun 19, 2013  /  Add to My Watchlist      
(VNDA) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
June 20, 2013
(Benzinga, 11/3/10)
Shares of Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) are currently up 7% at $7.96 per share during Wednesday afternoon trading. Today's trading range for shares of Vanda Pharmaceuticals Inc has been between $7.50 and $8.00 per share. The...(read more)
(Benzinga, 11/3/10)
Hapoalim Securities is out with a research report this morning, where it reiterates its Buy rating on Vanda Pharmaceuticals (NASDAQ: VNDA); it has a $15.00 price target on the stock. The HS analysts noted that Fanapt is catching up...(read more)
(Stock Blog Hub, 10/20/09)
Avnet, Inc. (AVT) recently announced that it has acquired a controlling interest in Vanda Group from Hutchinson Whampoa Limited in a strategic move to expand its presence and customer base across...(read more)
Vanda Pharmaceuticals (VNDA) Company Overview

There is no analysis for VNDA yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here